Author Remke, Marc
-
2013 | Journal Article
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Zhukova, N.; Ramaswamy, V.; Remke, M.; Pfaff, E.; Shih, D. J. H.; Martin, D. C. & Castelo-Branco, P. et al. (2013)
Journal of Clinical Oncology, 31(23) pp. 2927-+. DOI: https://doi.org/10.1200/JCO.2012.48.5052
Details DOI PMID PMC WoS
-
2014 | Journal Article |
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Zhukova, N.; Ramaswamy, V.; Remke, M.; Martin, D. C.; Castelo-Branco, P.; Zhang, C. H. & Fraser, M. et al. (2014)
Acta Neuropathologica Communications, 2(1) art. 174. DOI: https://doi.org/10.1186/s40478-014-0174-y
Details DOI PMID PMC
-
2014 | Journal Article |
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Pietsch, T.; Schmidt, R.; Remke, M.; Korshunov, A.; Hovestadt, V.; Jones, D. T. W. & Felsberg, J. et al. (2014)
Acta Neuropathologica, 128(1) pp. 137-149. DOI: https://doi.org/10.1007/s00401-014-1276-0
Details DOI PMID PMC WoS
-
2017 | Journal Article
Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response
Friedrich, C.; Shalaby, T.; Oehler, C.; Pruschy, M.; Seifert, B.; Picard, D. & Remke, M. et al. (2017)
Child's Nervous System, 33(9) pp. 1463-1471. DOI: https://doi.org/10.1007/s00381-017-3506-y
Details DOI